Today: 19 May 2026
Goldman Sachs stock holds steady after $14.75 billion bond sale as rate-cap politics hangs over banks
23 January 2026
2 mins read

Goldman Sachs stock holds steady after $14.75 billion bond sale as rate-cap politics hangs over banks

New York, Jan 22, 2026, 17:47 (EST) — After-hours

  • Goldman Sachs shares closed just above the previous session and held steady after the market closed.
  • A regulatory filing revealed the bank offloaded $14.75 billion in notes spanning four different maturities.
  • Investors are focused on Washington’s upcoming decisions about credit-card rates and the Fed meeting slated for next week.

Goldman Sachs shares nudged up 0.2% on Thursday and held steady in after-hours, last trading at $954.65. According to an SEC filing, the bank issued $14.75 billion in fixed-to-floating rate notes maturing from 2029 to 2047. These notes start with fixed coupons ranging from 4.148% to 5.541%, then switch to floating rates tied to compounded SOFR, the benchmark for overnight U.S. dollar borrowing costs.

The bond sale comes at a tricky time for the sector. Traders are sorting through what fresh policy discussions in Washington might mean for bank earnings—and how fast that could ripple into consumer behavior.

Goldman’s shares often reflect risk appetite in the deal space. SpaceX has tapped Bank of America, Goldman, JPMorgan, and Morgan Stanley for senior roles in a potential IPO, according to someone briefed on the plans. Investors will be watching any IPO move closely for signals that fee pools remain on the rise.

Policy uncertainty is shaking up stocks. Goldman slipped 1.9% Tuesday as investors gauged the chances of a Trump administration move to cap credit-card interest rates at 10%. Morgan Stanley took a bigger hit, falling 3.7% that day. Citigroup CEO Jane Fraser told CNBC the president’s focus on affordability makes sense, but warned that “capping rates would not be good for the U.S. economy.” Reuters

On Thursday, Bank of America explored launching new credit cards capped at a 10% interest rate, according to a source familiar with the situation. Citigroup is also reportedly mulling similar products, Bloomberg News told Reuters. The White House hasn’t detailed how it would enforce any broad rate cap, and analysts say new legislation would probably be necessary.

JPMorgan CEO Jamie Dimon ramped up his criticism a day earlier, branding a cap an “economic disaster” and warning it “would remove credit from 80% of Americans” during a Davos event. Brian Jacobsen, chief economic strategist at Annex Wealth Management, weighed in, saying the push for Congress makes a 10% cap “highly unlikely” anytime soon. Reuters

Goldman made waves beyond the usual banking chatter. The firm boosted its gold price forecast for the end of 2026 to $5,400 an ounce, up from $4,900. The upgrade reflects growing diversification by private investors and emerging-market central banks. In a note, Goldman said it “assumes” private-sector holders “don’t liquidate their gold holdings in 2026.” Reuters

Markets edged higher Thursday as the Dow climbed 0.63%, the S&P 500 gained 0.55%, and the Nasdaq rose 0.91%, following Trump’s retreat from tariff threats against European allies, according to Reuters. “You do not know whether it is Christmas morning or Friday the 13th,” remarked Gregg Abella, CEO of Investment Partners Asset Management. Reuters

Goldman’s near-term outlook remains headline-driven. Should a credit-card rate cap become workable legislation—or if the market judges enforcement likely—it could shake up consumer lending economics and hit sentiment across banks, including those with smaller card portfolios. The IPO pipeline might seem packed, but a spike in volatility could still bring things to a halt.

The Federal Reserve’s two-day policy meeting kicks off Jan. 27-28, with the statement set for 2:00 p.m. and a press conference at 2:30 p.m. on Jan. 28. Traders will be eyeing any firmer guidance from the White House and Congress on credit-card rate caps. They’ll also look for updates on whether SpaceX’s IPO plans are advancing beyond just assembling banker teams.

Stock Market Today

  • India IPO Fundraising Drops to Two-Year Low in Early 2026 with Uncertain Outlook for H2
    May 19, 2026, 6:19 AM EDT. India's IPO fundraising has plunged to Rs 56,322 crore in the first five months of 2026, marking a sharp decline from Rs 82,678 crore in the same period last year and a two-year low, according to Primedatabase. Contributing factors include market volatility, geopolitical tensions, and cautious investor behavior amid global uncertainties. Notably, average subscription rates fell to roughly 2x in early 2026 from 38x in H2 2025, signaling weakened appetite. Despite a healthy pipeline with major listings from NSE and Jio Platforms expected in the second half, experts warn recovery will be cautious and selective. Institutional investors now favor profitable, scalable firms over aggressive growth models. The primary market slowdown contrasts with record 2025 fundraising and raises concerns about H2 momentum.

Latest articles

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

19 May 2026
Hesai Group shares rose 2.68% to $22.60 in U.S. premarket trading after reporting a first-quarter profit and confirming it will supply lidar sensors for Mercedes-Benz Level 3 autonomous models. The company shipped 471,723 lidar units, up 140.9% year-on-year, and posted revenue of RMB680.6 million ($98.7 million). Net income reached RMB18.3 million, reversing a loss from a year earlier.
Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.

Popular

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.
Visa stock nudges higher as earnings near and Visa Direct expands crypto cash-outs
Previous Story

Visa stock nudges higher as earnings near and Visa Direct expands crypto cash-outs

Saudi Arabia gold price today slips after midweek jump as bullion tops $4,900
Next Story

Saudi Arabia gold price today slips after midweek jump as bullion tops $4,900

Go toTop